In today’s briefing:
- Aequitas: Cathay Pacific Placement – Swire Selling Shares Ahead of Its Prior Lockup Commitment
- Hang Seng Indexes: US$3.2bn of Flows Post Capping + Stock Connect Changes (Sep 2026)
- Aequitas: MiniMax Lockup Expiry – US$1.6bn Southbound Linked Lockup Release
- Shenzhen Longsys (9976 HK) IPO: Not Too Exciting
- ClubMed Pre-IPO: Tearsheet
- Aequitas: Ligent Pre-IPO – PHIP Update: Growth Reacceleration
- Longsys Electronics H Share Listing (9976 HK): The Investment Case
- Macro Monthly September 2026: Volatility Setups Emerge After a Sleepy August
- Aequitas: Transwarp Technology A/H Listing – PHIP Update
- Ligent Technologies (LGT HK): Synthetic Expert Call Transcript (01 Sep 2026)
Aequitas: Cathay Pacific Placement – Swire Selling Shares Ahead of Its Prior Lockup Commitment
- Swire Pacific (19 HK) is raising up to US$612m from a selldown in Cathay Pacific (293 HK) to fund the repurchase of an exchangeable bond due in 2027.
- This follows a prior sell-down in early March 2026, via a club deal and comes ahead of the lockup expiry.
- In this note, we comment on the deal dynamics and run the deal through our ECM framework.
Hang Seng Indexes: US$3.2bn of Flows Post Capping + Stock Connect Changes (Sep 2026)
- The changes to the Hang Seng family of indices were announced post market close on 21 August – final capping will use closing prices from the close on 1 September.
- There are 2 adds for the HSI, no constituent changes HSCEI, 1 change for the HSTECH, 5 changes for the HSIII, and 1 change for the HSBIO.
- There are 61 adds and 15 deletes for the Hang Seng Composite Index and that should lead to 54 additions to Southbound Stock Connect from the open on 7 September.
Aequitas: MiniMax Lockup Expiry – US$1.6bn Southbound Linked Lockup Release
- MiniMax (100 HK), an AI foundation model company, raised around US$700m in its Hong Kong listing in January 2026. A second set of shares are set to be unlocked soon.
- Minimax’s foundation model suite includes large language models, video generation models, and models for speech and music generation.
- In this note, we will talk about the lockup dynamics and possible placement.
Shenzhen Longsys (9976 HK) IPO: Not Too Exciting
- The IPO of Shenzhen Longsys Electronics (9976 HK), a branded independent semiconductor memory product enterprise, does not appear particularly attractive to us.
- Although its EPS CAGR will reach 95.5% for FY25-28, the growth is entirely generated in FY26, as market consensus projects a decline in FY27 and FY28.
- Its FY27 PER of 8x is higher than global peers, and the steep 45.9% discount to the A-share is justified by the uncertain earnings outlook.
ClubMed Pre-IPO: Tearsheet
- ClubMed, a premium all-inclusive resort operator, has filed its prospectus with the HKEX. BNP Paribas, HSBC, and JPM are the joint sponsors.
- We look at the company’s core segments: Club Med resort operations and vacation scenario services.
- We then look at the company’s financial profile, profit decline, ownership structure and pre-IPO backing.
Aequitas: Ligent Pre-IPO – PHIP Update: Growth Reacceleration
- Ligent Technologies (LGT HK) is looking to raise about US$800m in its upcoming Hong Kong IPO.
- It develops, manufactures and sells optical transceivers, optical chips and optical network terminals.
- In this note, we look at the company’s PHIP update.
Longsys Electronics H Share Listing (9976 HK): The Investment Case
- Shenzhen Longsys Electronics (9976 HK) is a branded independent memory product company. It is seeking to raise US$798 million.
- It designs controllers/firmware, back-end manufacturing (packaging/testing/assembly), and sells memory products (embedded storage, SSDs, mobile storage, DIMMs).
- The investment case is bearish as Longsys is a fundamentally commoditised, cyclical, cash-burning company, currently riding an exceptional AI-driven up-cycle.
Macro Monthly September 2026: Volatility Setups Emerge After a Sleepy August
- August’s sleepy performance gives way to a historically challenging September backdrop, although macro conditions may overwhelm the usual seasonal patterns.
- CSI300 and Kospi offer sharply contrasting historical September vol premium patterns, making both assets particularly interesting this month.
- Potential hedging opportunities emerge with historical September behaviour placing Kospi and HSI firmly among the markets worth watching.
Aequitas: Transwarp Technology A/H Listing – PHIP Update
- Transwarp Technology (688031 CH) , an AI infrastructure software provider, aims to raise around US$100m in its H-share listing.
- Transwarp Technology (Shanghai) Co (TTC) is an AI infrastructure software provider in China.
- In this note, we talk about the company’s updates in its PHIP.
Ligent Technologies (LGT HK): Synthetic Expert Call Transcript (01 Sep 2026)
- The Strategic Illusion of Vertical Integration: Ligent Technologies markets a “full-stack” model of self-researched optical chips and module assembly, but its optical chip division is a severe operational drag. The segment suffered deeply negative gross margins of -157.4% in 2024 and -121.0% in 2025 due to low yields on high-speed Electrabsorptive Modulated Lasers (EMLs) and high fixed asset depreciation, forcing Ligent to rely on external suppliers like Broadcom and Lumentum for high-end modules.
- Aggressive Pricing Driving Margin Erosion: To capture market share, Ligent has adopted a “price-for-volume” strategy, offering datacom optical modules at an average selling price (ASP) roughly one-third of market leaders like Zhongji Innolight. While this fueled a revenue surge to RMB 8.35 billion in 2025, it structurally degraded their datacom optical module gross margins from 28.9% in 2023 to 24.4% in 2025, demonstrating weak pricing power and limited operating leverage.
- Geopolitical Capital Imperative: The primary driver behind Ligent’s pending Hong Kong IPO—which cleared its listing hearing on August 31, 2026—is to fund a localized geopolitical hedge. Facing an extreme customer concentration risk where the top five customers account for over 70% of revenue, Ligent must rapidly deploy capital to build localized assembly lines in the United States and Southeast Asia by late 2026 to bypass trade barriers and remain viable for Western hyperscalers.
Disclaimer: The following transcripts are synthetic, AI-generated on demand, and compiled exclusively from public data sources; no real-word experts were actually interviewed. This content is designed to highlight potential market mispricings, explore compelling lines of inquiry, and suggest strategic questions rather than present verified facts. All specific financial metrics and data points, including market shares, TAM, margins, and growth rates, are AI-estimated approximations. They may be inaccurate and must be independently verified.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
